ID   PUR3_ECOLI              Reviewed;         212 AA.
AC   P08179;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   15-MAR-2017, entry version 156.
DE   RecName: Full=Phosphoribosylglycinamide formyltransferase {ECO:0000255|HAMAP-Rule:MF_01930};
DE            EC=2.1.2.2 {ECO:0000255|HAMAP-Rule:MF_01930, ECO:0000269|PubMed:2185839, ECO:0000269|PubMed:350869};
DE   AltName: Full=5'-phosphoribosylglycinamide transformylase {ECO:0000255|HAMAP-Rule:MF_01930};
DE   AltName: Full=GAR transformylase {ECO:0000255|HAMAP-Rule:MF_01930};
DE            Short=GART {ECO:0000255|HAMAP-Rule:MF_01930};
GN   Name=purN {ECO:0000255|HAMAP-Rule:MF_01930,
GN   ECO:0000303|PubMed:3301838}; OrderedLocusNames=b2500, JW2485;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=3301838;
RA   Smith J.M., Daum H.A. III;
RT   "Identification and nucleotide sequence of a gene encoding 5'-
RT   phosphoribosylglycinamide transformylase in Escherichia coli K12.";
RL   J. Biol. Chem. 262:10565-10569(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ECOR 7;
RX   PubMed=10954745; DOI=10.1073/pnas.180094797;
RA   Pupo G.M., Lan R., Reeves P.R.;
RT   "Multiple independent origins of Shigella clones of Escherichia coli
RT   and convergent evolution of many of their characteristics.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10567-10572(2000).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-6, FUNCTION, CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=2185839; DOI=10.1021/bi00458a014;
RA   Inglese J., Johnson D.L., Shiau A., Smith J.M., Benkovic S.J.;
RT   "Subcloning, characterization, and affinity labeling of Escherichia
RT   coli glycinamide ribonucleotide transformylase.";
RL   Biochemistry 29:1436-1443(1990).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=350869;
RA   Dev I.K., Harvey R.J.;
RT   "N10-Formyltetrahydrofolate is the formyl donor for glycinamide
RT   ribotide transformylase in Escherichia coli.";
RL   J. Biol. Chem. 253:4242-4244(1978).
RN   [8]
RP   MUTAGENESIS OF ASP-144, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2204419; DOI=10.1021/bi00480a018;
RA   Inglese J., Smith J.M., Benkovic S.J.;
RT   "Active-site mapping and site-specific mutagenesis of glycinamide
RT   ribonucleotide transformylase from Escherichia coli.";
RL   Biochemistry 29:6678-6687(1990).
RN   [9]
RP   MUTAGENESIS OF ASN-106; HIS-108; HIS-119; SER-135; HIS-137 AND
RP   ASP-144, AND PATHWAY.
RX   PubMed=8688421; DOI=10.1021/bi9528715;
RA   Warren M.S., Marolewski A.E., Benkovic S.J.;
RT   "A rapid screen of active site mutants in glycinamide ribonucleotide
RT   transformylase.";
RL   Biochemistry 35:8855-8862(1996).
RN   [10]
RP   MUTAGENESIS OF HIS-108; HIS-121 AND ASP-144, AND ACTIVE SITE.
RX   PubMed=10433709; DOI=10.1021/bi9904609;
RA   Shim J.H., Benkovic S.J.;
RT   "Catalytic mechanism of Escherichia coli glycinamide ribonucleotide
RT   transformylase probed by site-directed mutagenesis and pH-dependent
RT   studies.";
RL   Biochemistry 38:10024-10031(1999).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOG.
RX   PubMed=1522592; DOI=10.1016/0022-2836(92)90698-J;
RA   Chen P., Schulze-Gahmen U., Stura E.A., Inglese J., Johnson D.L.,
RA   Marolewski A., Benkovic S.J., Wilson I.A.;
RT   "Crystal structure of glycinamide ribonucleotide transformylase from
RT   Escherichia coli at 3.0-A resolution. A target enzyme for
RT   chemotherapy.";
RL   J. Mol. Biol. 227:283-292(1992).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS.
RX   PubMed=1631098; DOI=10.1073/pnas.89.13.6114;
RA   Almassy R.J., Janson C.A., Kan C.-C., Hostomska Z.;
RT   "Structures of apo and complexed Escherichia coli glycinamide
RT   ribonucleotide transformylase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:6114-6118(1992).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF MUTANT ALA-70 IN COMPLEX WITH
RP   SUBSTRATE ANALOGS, AND SUBUNIT.
RX   PubMed=9698564; DOI=10.1006/jmbi.1998.1931;
RA   Su Y., Yamashita M.M., Greasley S.E., Mullen C.A., Shim J.H.,
RA   Jennings P.A., Benkovic S.J., Wilson I.A.;
RT   "A pH-dependent stabilization of an active site loop observed from low
RT   and high pH crystal structures of mutant monomeric glycinamide
RT   ribonucleotide transformylase at 1.8 to 1.9 A.";
RL   J. Mol. Biol. 281:485-499(1998).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS.
RX   PubMed=10606510; DOI=10.1021/bi991888a;
RA   Greasley S.E., Yamashita M.M., Cai H., Benkovic S.J., Boger D.L.,
RA   Wilson I.A.;
RT   "New insights into inhibitor design from the crystal structure and NMR
RT   studies of Escherichia coli GAR transformylase in complex with beta-
RT   GAR and 10-formyl-5,8,10-trideazafolic acid.";
RL   Biochemistry 38:16783-16793(1999).
CC   -!- FUNCTION: Catalyzes the transfer of a formyl group from 10-
CC       formyltetrahydrofolate to 5-phospho-ribosyl-glycinamide (GAR),
CC       producing 5-phospho-ribosyl-N-formylglycinamide (FGAR) and
CC       tetrahydrofolate. {ECO:0000255|HAMAP-Rule:MF_01930,
CC       ECO:0000269|PubMed:2185839, ECO:0000269|PubMed:350869}.
CC   -!- CATALYTIC ACTIVITY: 10-formyltetrahydrofolate + N(1)-(5-phospho-D-
CC       ribosyl)glycinamide = tetrahydrofolate + N(2)-formyl-N(1)-(5-
CC       phospho-D-ribosyl)glycinamide. {ECO:0000255|HAMAP-Rule:MF_01930,
CC       ECO:0000269|PubMed:2185839, ECO:0000269|PubMed:350869}.
CC   -!- ENZYME REGULATION: Inhibited by N10-(bromoacetyl)-5,8-
CC       dideazafolate. {ECO:0000269|PubMed:2185839}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=77.5 uM for (6R)-N10-formyltetrahydrofolate (at pH 8.5)
CC         {ECO:0000269|PubMed:2185839};
CC         KM=84.8 uM for (6R)-N10-formyltetrahydrofolate (at pH 7.5)
CC         {ECO:0000269|PubMed:2185839};
CC         Note=kcat is 20.7 sec(-1) for (6R)-N10-formyltetrahydrofolate
CC         (at pH 8.5). kcat is 13.5 sec(-1) for (6R)-N10-
CC         formyltetrahydrofolate (at pH 7.5).
CC         {ECO:0000269|PubMed:2185839};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:2185839};
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide from N(1)-(5-
CC       phospho-D-ribosyl)glycinamide (10-formyl THF route): step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_01930, ECO:0000269|PubMed:8688421}.
CC   -!- SUBUNIT: Monomer. Homodimer below pH 6.8.
CC       {ECO:0000269|PubMed:10606510, ECO:0000269|PubMed:1522592,
CC       ECO:0000269|PubMed:1631098, ECO:0000269|PubMed:2185839,
CC       ECO:0000269|PubMed:9698564}.
CC   -!- SIMILARITY: Belongs to the GART family. {ECO:0000255|HAMAP-
CC       Rule:MF_01930, ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M13747; AAA83899.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75553.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16388.1; -; Genomic_DNA.
DR   EMBL; AF293167; AAG14584.1; -; Genomic_DNA.
DR   PIR; A28486; XYECGF.
DR   RefSeq; NP_416995.1; NC_000913.3.
DR   RefSeq; WP_001028612.1; NZ_LN832404.1.
DR   PDB; 1C2T; X-ray; 2.10 A; A/B=1-212.
DR   PDB; 1C3E; X-ray; 2.10 A; A/B=1-209.
DR   PDB; 1CDD; X-ray; 2.80 A; A/B=1-212.
DR   PDB; 1CDE; X-ray; 2.50 A; A/B/C/D=1-212.
DR   PDB; 1GAR; X-ray; 1.96 A; A/B=1-212.
DR   PDB; 1GRC; X-ray; 3.00 A; A/B=1-212.
DR   PDB; 1JKX; X-ray; 1.60 A; A/B/C/D=1-212.
DR   PDB; 2GAR; X-ray; 1.80 A; A=1-212.
DR   PDB; 3GAR; X-ray; 1.90 A; A=1-212.
DR   PDBsum; 1C2T; -.
DR   PDBsum; 1C3E; -.
DR   PDBsum; 1CDD; -.
DR   PDBsum; 1CDE; -.
DR   PDBsum; 1GAR; -.
DR   PDBsum; 1GRC; -.
DR   PDBsum; 1JKX; -.
DR   PDBsum; 2GAR; -.
DR   PDBsum; 3GAR; -.
DR   ProteinModelPortal; P08179; -.
DR   SMR; P08179; -.
DR   BioGrid; 4261440; 10.
DR   IntAct; P08179; 1.
DR   STRING; 511145.b2500; -.
DR   BindingDB; P08179; -.
DR   DrugBank; DB02236; Glycinamide Ribonucleotide.
DR   DrugBank; DB02794; N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide.
DR   PaxDb; P08179; -.
DR   PRIDE; P08179; -.
DR   EnsemblBacteria; AAC75553; AAC75553; b2500.
DR   EnsemblBacteria; BAA16388; BAA16388; BAA16388.
DR   GeneID; 946973; -.
DR   KEGG; ecj:JW2485; -.
DR   KEGG; eco:b2500; -.
DR   PATRIC; 32120389; VBIEscCol129921_2597.
DR   EchoBASE; EB0792; -.
DR   EcoGene; EG10799; purN.
DR   eggNOG; ENOG4108V3E; Bacteria.
DR   eggNOG; COG0299; LUCA.
DR   HOGENOM; HOG000033575; -.
DR   InParanoid; P08179; -.
DR   KO; K11175; -.
DR   OMA; FKGTHTH; -.
DR   PhylomeDB; P08179; -.
DR   BioCyc; EcoCyc:GART-MONOMER; -.
DR   BioCyc; MetaCyc:GART-MONOMER; -.
DR   UniPathway; UPA00074; UER00126.
DR   EvolutionaryTrace; P08179; -.
DR   PRO; PR:P08179; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0004644; F:phosphoribosylglycinamide formyltransferase activity; IDA:EcoCyc.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEP:EcoliWiki.
DR   CDD; cd08645; FMT_core_GART; 1.
DR   Gene3D; 3.40.50.170; -; 1.
DR   HAMAP; MF_01930; PurN; 1.
DR   InterPro; IPR002376; Formyl_transf_N.
DR   InterPro; IPR004607; GART.
DR   InterPro; IPR001555; GART_AS.
DR   Pfam; PF00551; Formyl_trans_N; 1.
DR   SUPFAM; SSF53328; SSF53328; 1.
DR   TIGRFAMs; TIGR00639; PurN; 1.
DR   PROSITE; PS00373; GART; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Purine biosynthesis; Reference proteome; Transferase.
FT   CHAIN         1    212       Phosphoribosylglycinamide
FT                                formyltransferase.
FT                                /FTId=PRO_0000074943.
FT   REGION       11     13       5'-phosphoribosylglycinamide binding.
FT                                {ECO:0000255|HAMAP-Rule:MF_01930,
FT                                ECO:0000269|PubMed:10606510,
FT                                ECO:0000269|PubMed:1631098}.
FT   REGION       89     92       10-formyltetrahydrofolate binding.
FT                                {ECO:0000255|HAMAP-Rule:MF_01930,
FT                                ECO:0000269|PubMed:10606510,
FT                                ECO:0000269|PubMed:1631098}.
FT   REGION      140    144       10-formyltetrahydrofolate binding.
FT                                {ECO:0000269|PubMed:10606510,
FT                                ECO:0000269|PubMed:1631098}.
FT   REGION      170    173       5'-phosphoribosylglycinamide binding.
FT                                {ECO:0000269|PubMed:10606510,
FT                                ECO:0000269|PubMed:1631098}.
FT   ACT_SITE    108    108       Proton donor. {ECO:0000255|HAMAP-
FT                                Rule:MF_01930,
FT                                ECO:0000269|PubMed:10433709}.
FT   BINDING      64     64       10-formyltetrahydrofolate.
FT                                {ECO:0000255|HAMAP-Rule:MF_01930,
FT                                ECO:0000269|PubMed:10606510}.
FT   BINDING     106    106       10-formyltetrahydrofolate.
FT                                {ECO:0000255|HAMAP-Rule:MF_01930,
FT                                ECO:0000269|PubMed:10606510}.
FT   SITE        144    144       Raises pKa of active site His.
FT                                {ECO:0000255|HAMAP-Rule:MF_01930,
FT                                ECO:0000269|PubMed:10433709}.
FT   MUTAGEN      70     70       E->A: Loss of homodimerization. No effect
FT                                on activity.
FT                                {ECO:0000269|PubMed:9698564}.
FT   MUTAGEN     106    106       N->A,D,G,S: Reduces activity about 2000-
FT                                fold. {ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     106    106       N->E,H,I,K,L,Y: Loss of activity.
FT                                {ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     108    108       H->A,G,M,N,Q,R: Loss of activity.
FT                                {ECO:0000269|PubMed:10433709,
FT                                ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     108    108       H->E,S,T: Reduces activity about 1000-
FT                                fold. {ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     119    119       H->A: No effect.
FT                                {ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     121    121       H->Q: Increases Km for 5'-
FT                                phosphoribosylglycinamide 4-fold.
FT                                {ECO:0000269|PubMed:10433709}.
FT   MUTAGEN     135    135       S->A,L: Reduces activity about 1000-fold.
FT                                {ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     137    137       H->F,Q: No effect.
FT                                {ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     144    144       D->A,E,S,Y: Reduces activity about 1000-
FT                                fold. {ECO:0000269|PubMed:10433709,
FT                                ECO:0000269|PubMed:8688421}.
FT   MUTAGEN     144    144       D->C,F,H,K,L,N,P,Q,R,T,V: Loss of
FT                                activity. {ECO:0000269|PubMed:2204419,
FT                                ECO:0000269|PubMed:8688421}.
FT   STRAND        2      9       {ECO:0000244|PDB:1JKX}.
FT   HELIX        12     22       {ECO:0000244|PDB:1JKX}.
FT   STRAND       25     36       {ECO:0000244|PDB:1JKX}.
FT   HELIX        41     48       {ECO:0000244|PDB:1JKX}.
FT   STRAND       52     55       {ECO:0000244|PDB:1JKX}.
FT   HELIX        58     60       {ECO:0000244|PDB:1JKX}.
FT   STRAND       61     63       {ECO:0000244|PDB:2GAR}.
FT   HELIX        64     75       {ECO:0000244|PDB:1JKX}.
FT   HELIX        76     78       {ECO:0000244|PDB:1JKX}.
FT   STRAND       81     87       {ECO:0000244|PDB:1JKX}.
FT   HELIX        94     99       {ECO:0000244|PDB:1JKX}.
FT   TURN        100    102       {ECO:0000244|PDB:1JKX}.
FT   STRAND      103    110       {ECO:0000244|PDB:1JKX}.
FT   STRAND      112    114       {ECO:0000244|PDB:3GAR}.
FT   HELIX       120    126       {ECO:0000244|PDB:1JKX}.
FT   STRAND      130    138       {ECO:0000244|PDB:1JKX}.
FT   STRAND      141    146       {ECO:0000244|PDB:3GAR}.
FT   STRAND      148    155       {ECO:0000244|PDB:1JKX}.
FT   HELIX       162    185       {ECO:0000244|PDB:1JKX}.
FT   STRAND      189    192       {ECO:0000244|PDB:1JKX}.
FT   STRAND      195    198       {ECO:0000244|PDB:1JKX}.
SQ   SEQUENCE   212 AA;  23238 MW;  D38F326BCBA103FB CRC64;
     MNIVVLISGN GSNLQAIIDA CKTNKIKGTV RAVFSNKADA FGLERARQAG IATHTLIASA
     FDSREAYDRE LIHEIDMYAP DVVVLAGFMR ILSPAFVSHY AGRLLNIHPS LLPKYPGLHT
     HRQALENGDE EHGTSVHFVT DELDGGPVIL QAKVPVFAGD SEDDITARVQ TQEHAIYPLV
     ISWFADGRLK MHENAAWLDG QRLPPQGYAA DE
//
